Emergency Medicine Cardiac Research and Education Group (EMCREG-International)

NAVIGATION

ACTION Registry®–GWTG™ is a national, risk-adjusted, outcomes-based quality improvement program that helps participating facilities measure and improve care for high-risk ACS patients with STEMI and NSTEMI. The result of the collaboration between the two leading national coronary artery disease registries, the NCDR® ACTION Registry® and the American Heart Association (AHA) Get With The GuidelinesSM-CAD Registry, ACTION Registry–GWTG will be the largest, most comprehensive national cardiovascular patient database ever developed by the medical profession.

Combining the strengths of the two programs, ACTION Registry–GWTG will collect a comprehensive set of data elements that provide healthcare professionals and their facilities with the information they need to monitor and improve adherence to the most current, science-based ACC/AHA treatment guidelines. Participation will greatly facilitate quality improvement efforts, optimize clinical care, and improve clinical outcomes for acute coronary syndrome patients.

Visit How To Join to request additional information or to download an enrollment package. Or, visit the ACTION website for more information.


OPTIMAL THERAPY FOR HYPERTENSIVE EMERGENCIES, HEART FAILURE, STROKE, AND UNDERSTANDING THE IMPACT OF THE OBESITY EPIDEMIC FORMAT: Slides with audio via web EVENT DATE: Tuesday November 9, 2010 Available Now On-Demand: Click Here Obesity: The Highly Visible Killer - Andra L. Blomkalns, MD; Treating Acute and Hemorrhagic Stroke – What is the "State of the Art"? - Arthur M. Pancioli, MD; Hypertensive Emergencies: Optimal Therapy in the ED - Phillip D. Levy, MD, MPH; Management of Acute Heart Failure in the Emergency Department - Alan B. Storrow, MD		OPTIMIZING CARE FOR PATIENTS WITH ACS IN THE EMERGENCY DEPARTMENT FORMAT: Slides with audio via web EVENT DATE: Tuesday November 9, 2010 Available Now On-Demand: Click Here Risk Stratification of Acute Coronary Syndrome in the Emergency Department - W. Brian Gibler, MD; Anti-Coagulant Therapy for ACS: Optimal Care in the ED - Charles V. Pollack, MD; Optimal Use of Thienopyridine Anti-platelet Therapy for ACS - James W. Hoekstra, MD; Controversies in the ED Use Anti-platelet Therapy for ACS - Deborah B. Diercks, MD

ACEP 2010 AUDIO CAST: OPTIMIZING CARE FOR PATIENTS WITH ACS IN THE EMERGENCY DEPARTMENT MEDIA TYPE: Audio EVENT DATE: September 29, 2010 Available Now On-Demand: Click Here This event was held during ACEP 2010. Assess and formulate practical strategies for improving the management of ACS in the emergency department. In this audio recording of the live, emergency medicine symposium sponsored by Med-IQ in collaboration with EMCREG-International, expert faculty discuss the evolving landscape of antiplatelet agents and the complexities of thienopyridines and review the most up-to-date recommendations and strategies for triage and transfer to meet reperfusion goals. Presentations include: W. Brian Gibler, MD, Charles V. Pollack, MD, JamesW. Hoekstra, MD, and Deborah B. Diercks, MD.

NEW! 2010 ADVANCING THE STANDARD OF CARE: CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES

Monograph based on the 2010 Web Symposia held October 19 and November 9, 2010. The events covered important current and emerging acute care topics including risk stratification of ACS, ACS anticoagulation, thienopyridine therapy, novel antiplatelet agents prasugrel and ticagrelor, hypertensive emergencies, the obesity epidemic, acute heart failure treatment, and acute stroke.

View the work in PDF Format.

HEART FAILURE: BIOMARKERS OF DIAGNOSIS AND PROGNOSIS

Heart Failure remains a common presentation in the emergency department. For the emergency physician clarifying the course of the universal complaint, shortness of breath, requires excellent clinical acumen combined with a clear understanding of the laboratory tests available to distinguish Heart Failure from other causes of dyspnea. Dr. Frank Peacock of the Cleveland Clinic authors an excellent discussion of the scientific basis for the use of the natriuretic peptide biomarkers in heart failure including future markers currently being investigated.

View the work in PDF Format.

ACEP 2009 MONOGRAPH: ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES

EMCREG–International is pleased to present this complimentary CME monograph covering the proceedings of our 2009 satellite symposium at the ACEP Scientific Assembly in Boston, MA. The monograph covers a number of important topics including acute coronary syndromes (ACS) including non-ST-segment elevation ACS (NSTE ACS) and ST-segment elevation myocardial infarction (STEMI), acute heart failure syndromes, STEMI Regional Systems of Care, and medical-legal issues of acute stroke.

View the work in Multiple Formats including by webcast.

ACEP 2008 MONOGRAPH: ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES

EMCREG–International is pleased to present this complimentary CME monograph covering the proceedings of our 2008 satellite symposium at the ACEP Scientific Assembly in Chicago, IL. The monograph covers the presented topics and provides up-to-date knowledge on the full spectrum of decision making and care for patients with acute coronary syndromes (ACS) including non-ST-segment elevation ACS (NSTE ACS) and ST-segment elevation myocardial infarction (STEMI), acute heart failure syndromes, pulmonary embolism, and acute ischemic stroke.

View the work in Multiple Formats including by webcast.

HYPERTENSIVE EMERGENCIES: ACUTE CARE EVALUATION AND MANAGEMENT

Hypertension remains one of the most common disease processes in patients presenting to the Emergency Department (ED). While sometimes symptomatic and associated with end organ damage such as hypertensive encephalopathy, hemorrhagic stroke, acute coronary syndrome, heart failure, and renal insufficiency, many patients present without symptoms. Emergency physicians and hospitalists should understand the appropriate classification of patients with hypertension, the pathophysiology of this disease process, and appropriate treatment strategies. In this EMCREG-International Newsletter, Charles V. Pollack, Jr. MD and Christopher J. Rees, MD of Pennsylvania Hospital and the University of Pennsylvania discuss hypertension and parenteral medications used for treatment of these patients in the ED.

View the work in PDF Format.

View the monograph archive . . .

Can the HEART Score Safely Reduce Stress Testing and Cardiac Imaging in Patients at Low Risk for Major Adverse Cardiac Events?

Mahler S, Hiestand B, Gof D, Joekstra JW, Miller C

Crit Pathways in Cardiol 2011;10: 128–133

Care Processes Associated With Quicker Door-In–Door-Out Times for Patients With ST-Elevation–Myocardial Infarction Requiring Transfer: Results From a Statewide Regionalization Program

Glickman SW, Lytle BL, Ou F, Mears G, O'Brien S, Cairns CB, Garvey JL, Bohle DJ, Peterson ED, Jollis JG, and Granger CB

Circ Cardiovasc Qual Outcomes. 2011;4:382-388

Comparison of Cardiac Risk Scores in ED Patients With Potential Acute Coronary Syndrome

Lee B, Chang AM, Matsuura AC, Marcoon S, Hollander HE

Crit Pathways in Cardiol 2011;10: 64–68

Upstream treatment of acute coronary syndrome in the ED

Kirk JD, Kontos M, Diercks DB

Am J Emerg Med 2011 May;29(4):446-56

2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

2011 Writing Group Members, Wright RS, Anderson LL, Adams CD, Bridges CR, Casey DE, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Jacobs AK

Circulation 2011;123 2022-2060

The future of point-of-care testing in emergency departments

Zydron CT, Woodworth A, Storrow AB

Expert Opin. Med. Diagn. (201I) 5(3):175-181

Placental Growth Factor and B-Type Natriuretic Peptide as Independent Predictors of Risk from a Multibiomarker Panel in Suspected Acute Coronary Syndrome (Acute Risk and Related Outcomes Assessed With Cardiac Biomarkers [ARROW]) Study

Glaser R, Peacock WF, Wu AHB , Muller R, Möckel M, Apple FS

Am J Cardiol 2011;107:821– 826

A Report of Quality Improvement in the Care of Patients With Acute Coronary Syndromes

Cannon CP, Hoekstra JW, Larson DM, Karcher RB, Mencia WA, Berry CA, Stowell SA

Crit Pathways in Cardiol 2011;10: 29–34

View our member publication archive . . .

Legal information

EMCREG™ - International
231 Albert Sabin Way
MSB Suite 1552
Cincinnati, Ohio 45267-0769

Fell free to contact us toll-free at 1-866-4EMCREG (436-2734)